Mercator Medical (STU:MM2) Cyclically Adjusted Revenue per Share: €21.88 (As of Mar. 2026)


STU:MM2 Mercator Medical SA STU:MM2
63 GF Score
Price €11.68
GF Value €11.49
! 2 Warning Signs
View Full Analysis

What is Mercator Medical Cyclically Adjusted Revenue per Share?

Mercator Medical STU:MM2 -0.34% 63 Cyclically Adjusted Revenue per Share is €21.88 as of Mar. 2026. GuruFocus rates STU:MM2 with a GF Score™ of 63/100 and a GF Value™ of €11.49. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Mercator Medical's adjusted revenue per share for the three months ended in Mar. 2026 was €3.654. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €21.88 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Mercator Medical's average Cyclically Adjusted Revenue Growth Rate was 5.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Mercator Medical was 7.40% per year. The lowest was 7.40% per year. And the median was 7.40% per year.

As of today (2026-07-13), Mercator Medical's current stock price is €11.68. Mercator Medical's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €21.88. Mercator Medical's Cyclically Adjusted PS Ratio of today is 0.53.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Mercator Medical was 0.74. The lowest was 0.40. And the median was 0.51.


Mercator Medical  (STU:MM2) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Mercator Medical's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=11.68/21.88
=0.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Mercator Medical was 0.74. The lowest was 0.40. And the median was 0.51.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Mercator Medical Cyclically Adjusted Revenue per Share Related Terms


Mercator Medical Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Mercator Medical's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mercator Medical Cyclically Adjusted Revenue per Share Chart

Mercator Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 16.41 18.64 20.57 21.38

Mercator Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.49 21.06 21.25 21.38 21.88

STU:MM2 vs ISRG, BDX, MDLN: Cyclically Adjusted Revenue per Share Comparison

For the Medical Instruments & Supplies subindustry, Mercator Medical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mercator Medical Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Mercator Medical's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Mercator Medical's Cyclically Adjusted PS Ratio falls into.


STU:MM2
63GF Score
Mercator Medical SA STU:MM2
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mercator Medical Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Mercator Medical's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=3.654/163.0700*163.0700
=3.654

Current CPI (Mar. 2026) = 163.0700.

Mercator Medical Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 1.786 99.552 2.926
201609 1.768 99.064 2.910
201612 1.393 100.366 2.263
201703 1.594 101.018 2.573
201706 1.624 101.180 2.617
201709 1.657 101.343 2.666
201712 1.642 102.564 2.611
201803 1.931 102.564 3.070
201806 1.913 103.378 3.018
201809 2.411 103.378 3.803
201812 2.854 103.785 4.484
201903 2.626 104.274 4.107
201906 2.954 105.983 4.545
201909 3.140 105.983 4.831
201912 2.975 107.123 4.529
202003 4.394 109.076 6.569
202006 8.079 109.402 12.042
202009 12.996 109.320 19.386
202012 14.379 109.565 21.401
202103 12.163 112.658 17.606
202106 11.828 113.960 16.925
202109 8.296 115.588 11.704
202112 6.538 119.088 8.953
202203 3.214 125.031 4.192
202206 3.504 131.705 4.338
202209 3.263 135.531 3.926
202212 2.760 139.113 3.235
202303 2.665 145.950 2.978
202306 2.919 147.009 3.238
202309 2.837 146.113 3.166
202312 2.810 147.741 3.102
202403 3.190 149.044 3.490
202406 2.994 150.997 3.233
202409 3.398 153.439 3.611
202412 3.679 154.660 3.879
202503 3.655 157.021 3.796
202506 3.547 157.509 3.672
202509 3.604 158.000 3.720
202512 3.463 158.320 3.567
202603 3.654 163.070 3.654

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €21.88 mean?
Mercator Medical (STU:MM2) has a Cyclically Adjusted Revenue per Share of €21.88 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Mercator Medical and its competitors.
Is Mercator Medical's Cyclically Adjusted Revenue per Share too high?
Mercator Medical's current Cyclically Adjusted Revenue per Share is €21.88. Overall, Mercator Medical has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Mercator Medical's Cyclically Adjusted Revenue per Share compare to ISRG and BDX?
Mercator Medical's Cyclically Adjusted Revenue per Share of €21.88 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Mercator Medical and its competitors. Mercator Medical's current Cyclically Adjusted Revenue per Share is €21.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mercator Medical stock overvalued right now?
Mercator Medical (STU:MM2) has a current Cyclically Adjusted Revenue per Share of €21.88. The stock's GF Value™ is €11.49, compared to a current price of €11.68 — trading 1.7% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is €21.88. Mercator Medical's overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Mercator Medical (STU:MM2), the current Cyclically Adjusted Revenue per Share is €21.88 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mercator Medical (STU:MM2) Overvalued in 2026?

Based on GuruFocus' analysis, Mercator Medical stock appears to be overvalued. The current stock price of €11.68 is trading 1.7% above its estimated GF Value™ of €11.49.

Key valuation signals for STU:MM2:

  • Cyclically Adjusted Revenue per Share: €21.88
  • GF Value™: €11.49 vs. price of €11.68 (1.7% above fair value)
  • GF Score™: 63/100 with 2 warning signs

No single metric tells the full story. See the STU:MM2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mercator Medical Business Description

Other Exchanges MRC:PolandMM2:Germany
Address Ulica H. Modrzejewska 30, Krakow, POL, 31-327
Mercator Medical SA produces and sells medical gloves and distributor of medical disposables. The company's products - mainly gloves, dressings, disposable clothing and surgical drapes. It operates in Europe and Russia.
63GF Score

Get the complete analysis for STU:MM2

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.68
Price
€11.49
GF Value